Newsroom

Group picture of 6 people with an oversized cheque

News

A novel oral immunotherapy for cancer and a drug for treating chronic liver fibrosis: What many patients are hoping for is already a part of cutting-edge research in Lower Saxony. To ensure that such innovative ideas are translated into practical applications more quickly, the state of Lower Saxony is funding particularly promising projects: “Citrapeutics” from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and “RNA Healer” from the Hannover Medical School (MHH) will receive a total of nearly €2.5 million in funding from the Institute for Biomedical Translation (IBT) Lower Saxony to spur their innovations.

19.11.2025

TWINCORE

HZI Campus

News

In Germany, around 10,000 people die every year from antibiotic-resistant pathogens. At the Helmholtz Centre for Infection Research (HZI) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), scientists are using artificial intelligence to find new antibiotics. In particular, they are looking for active substances that circumvent known resistance mechanisms. They are supported by citizen scientists sending them soil samples from various habitats. On the occasion of World Antimicrobial Resistance Awareness Week 2025, the Helmholtz Association explains how the researchers are fighting against multi-resistant germs.

18.11.2025

HIPS

HZI Campus

Portrait Dr. Felix Deschner and Dr. Max Kellner with their prizes

News

PhD students play a crucial role in the advancement of knowledge and technologies that shape our world. At the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its locations, more than 300 doctoral students are working on solving important questions in infection research. Two HZI scientists have now been honored for their successful doctoral theses. Dr. Felix Deschner, postdoc at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), was awarded the Eduard Martin Prize of Saarland University. HZI junior research group leader Dr. Max Kellner received the PhD Award of the Vienna BioCenter for his doctoral thesis at the Institute of Molecular Biotechnology (IMBA) in Vienna.

17.11.2025

HIPS

HZI Campus

[Translate to English:] Rasterelektronenmikroskopische Aufnahme einer Escherichia coli-Zelle (rot), die von Bakteriophagen (grün) infiziert wird.

Story

Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in the first place. But their success has a downside: More and more bacteria are developing strategies to evade the attacks of these drugs. Resistant germs are spreading around the globe, against which hardly any drugs are effective. With the annual World Antimicrobial Resistance Awareness Week (WAAW) from 18 to 24 November, the World Health Organization reminds us how important it is to use antibiotics carefully and how urgently new approaches are needed to continue fighting infections effectively in the future. Almost 20 research groups in the research topic “Novel Anti-Infectives” at the Helmholtz Centre for Infection Research (HZI) are developing new drugs against infectious diseases.

17.11.2025

HZI Campus

HIOH

HIRI

News

The company Clarivate Analytics publishes an annual list of “Highly-cited Researchers” to recognize scientists whose publications have had a particularly large impact on their field. In 2025, three researchers from the Helmholtz Centre for Infection Research (HZI) are once again among the honorees: bioinformatician Prof. Andreas Keller, molecular biologist Dr. Max Kellner and biotechnologist Prof. Marc Stadler were recognized for their widely cited research and the significant contribution they have made to their respective disciplines.

12.11.2025

HZI Campus

HIPS

News

During the 20th anniversary celebrations of the Academy of Sciences in Hamburg , Fabian Leendertz, founding director of the Helmholtz Institute for One Health (HIOH), was inducted as a full member. The ceremony took place on 16 October 2025 in Hamburg. Five new members joined the interdisciplinary network, which currently comprises 145 leading scientists from northern Germany. HIOH is a site of the Helmholtz Centre for Infection Research (HZI).

11.11.2025

HIOH

HZI in the media

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026

News Medical

... basierte Infektionsforschung (HIRI) in Würzburg nachweisen. Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung ...

07.01.2026

DeutschesGesundheitsPortal

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026

Trading View

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026

Biermann Medizin

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025

Tagesschau

Erkrankungen. Eine Arbeitsgruppe des TWINCORE Helmholtz Zentrum für Infektionsforschung ( HZI ) und der Medizinischen Hochschule Hannover ( ...

30.12.2025

Deutsches Ärzteblatt

Forschungsteam um Tobias Gulder, Abteilungsleiter am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), ist es ...

29.12.2025

Biermann Medizin

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

29.12.2025

Das PTA Magazin

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Forschende vom Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

17.12.2025

Verband Deutscher Biologen e.V.

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.